Related Experiment Video
Updated: Aug 5, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Astrakurkurone targets multidrug resistant Staphylococcus aureus biofilms through ROS-mediated cell membrane damage
Shrabasti Bandyopadhyay1, Soma Mondal2, Krishnendu Acharya3
1Antimicrobial Resistance Research Laboratory, Department of Microbiology, University of Kalyani, Kalyani, Kalyani, West Bengal, 741235, India.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) pose a formidable health threat owing to their multidrug resistance (MDR) nature, robust biofilms and persistence. Natural product-based medications are a highly viable strategy for challenging MDR and biofilm persistence with diverse therapeutic benefits. In this study, the triterpenoid Astrakurkurone, previously purified from a wild edible mushroom Astraeus hygrometricus, showed antibacterial efficacy against MRSA BAA1717 and a clinical isolate (MRSA CI-1) with MICs ranging from 150 to 300 μg/mL. 1/2 MIC concentration of Astrakurkurone also inhibited 93.95% and 88.31% of MRSA BAA1717 and MRSA CI-1 biofilms through downregulating quorum sensing and virulence factors such as agrA, sarA, bap, sasG, icaA, and hla. The inhibition of staphyloxanthin production by Astrakurkurone was another interesting insight, sensitizing bacterial cells to reactive oxygen species (ROS). The accumulation of ROS was observed as one of the primary mechanisms of Astrakurkurone that affected potential and integrity of cell membrane. Intriguingly, Astrakurkurone acted as a β-lactamase inhibitor by downregulating blaZ expression by ∼11.11 fold. Moreover, a synergistic and additive interaction of Astrakurkurone with β-lactam antibiotic cefoxitin was evinced, supporting its β-lactamase inhibitory nature. Furthermore, the antibiotic-induced and biofilm-induced persister cells were eliminated by Astrakurkurone, providing another important insight for recurrent and chronic disease management. Astrakurkurone eradicated matured biofilms from urinary catheter, goat skin wound, skin burn wound and lung sections, strengthening applicability potential. In summary, the antibiofilm, antivirulence and antipersister nature of Astrakurkurone could emerge as a promising therapeutic alternative for the cure of medicinal implant-associated maladies, severe skin and lung infections with enhanced efficacy.
Insights
Astrakurkurone, a mushroom compound, effectively combats multidrug-resistant bacteria (MRSA) by inhibiting biofilms and virulence. It also acts as a beta-lactamase inhibitor and eliminates persister cells, offering a promising natural alternative for infections.
Area of Science:
- Natural Product Chemistry
- Microbiology
- Antimicrobial Resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant health challenge due to multidrug resistance (MDR) and biofilm formation.
- Natural products offer a promising avenue for developing new strategies against resistant bacterial strains.
Purpose of the Study:
- To investigate the antibacterial, antibiofilm, and antivirulence potential of the triterpenoid Astrakurkurone from Astraeus hygrometricus against MRSA.
- To elucidate the mechanisms of action of Astrakurkurone, including its effects on quorum sensing, virulence factors, and beta-lactamase activity.
Main Methods:
- Antibacterial efficacy was determined by minimum inhibitory concentrations (MICs).
- Biofilm inhibition was assessed by quantifying biofilm mass and downregulating key virulence genes (agrA, sarA, bap, sasG, icaA, hla).
- Mechanisms explored included staphyloxanthin inhibition, reactive oxygen species (ROS) generation, beta-lactamase inhibition (blaZ expression), and synergistic effects with cefoxitin.
Main Results:
- Astrakurkurone demonstrated antibacterial activity against MRSA strains (MICs 150-300 μg/mL) and significantly inhibited biofilm formation.
- It downregulated quorum sensing and virulence factors, inhibited staphyloxanthin, induced ROS accumulation, and acted as a beta-lactamase inhibitor.
- Astrakurkurone eradicated mature biofilms from various medical device and tissue models and eliminated persister cells.
Conclusions:
- Astrakurkurone exhibits significant antibiofilm, antivirulence, and antipersister properties against MRSA.
- Its multifaceted mechanisms, including beta-lactamase inhibition, highlight its potential as a therapeutic agent.
- Astrakurkurone shows promise for treating challenging infections, including those associated with medical implants and chronic conditions.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Biofilms
Antifungal Agents
Inhibitors of Gram-positive Cell Wall Synthesis

